The BCR-ABL fusion protein results in the Philadelphia chromosome and is present in 95% of chronic myeloid leukemia (CML) patients and 20–40% of adult acute lymphoblastic leukemia (ALL) patients. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.